Top Markets
Coin of the day
Ocumension Therapeutics Ocumension Therapeutics

Ocumension Therapeutics

1477
Rangering i aksjer #12973
Based in the People's Republic of China, Ocumension Therapeutics functions as a... Based in the People's Republic of China, Ocumension Therapeutics functions as a dedicated ophthalmic pharmaceutical platform. This company, along with its subsidiaries, is committed to the research, progression, and market introduction of therapeutic solutions for individuals with various eye conditions. Its extensive product offerings target treatments for disorders such as blepharitis, infectious and allergic conjunctivitis, dry eye syndrome, cataracts, glaucoma, ocular hypertension, post-surgical inflammation, uveitis, retinitis pigmentosa, age-related macular degeneration, corneal graft rejection, myopia, and optic neuritis. By December 31, 2021, Ocumension Therapeutics boasted a pipeline of 20 drug assets. The company, founded in 2017, maintains its headquarters in Suzhou, China.
Aksjekurs
$0.66137861
Markedsverdi
$531.70M
Endring (1 dag)
-2.45%
Endring (1 år)
-42.12%
Land
CN
Handel Ocumension Therapeutics (1477)

Kategori

P/B-forhold for Ocumension Therapeutics (1477)
P/B-forhold per 2026 TTM: 0
Ifølge Ocumension Therapeutics sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Ocumension Therapeutics fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
3.7087 -
US
- -
CH